Musculoskeletal manifestations of COVID-19.

Autor: da Silva LNM; Department of Musculoskeletal Radiology, Grupo Fleury, Sao Paulo, Brazil., Filho AGO; Department of Musculoskeletal Radiology, Grupo Fleury, Sao Paulo, Brazil., Guimarães JB; Department of Musculoskeletal Radiology, Grupo Fleury, Sao Paulo, Brazil. julio.brandaoguimaraes@ucsf.edu.; Department of Radiology, Universidade Federal de Sao Paulo, UNIFESP-EPM, Sao Paulo, Brazil. julio.brandaoguimaraes@ucsf.edu.; Department of Radiology and Biomedical Imaging, University of California, San Francisco, USA. julio.brandaoguimaraes@ucsf.edu.
Jazyk: angličtina
Zdroj: Skeletal radiology [Skeletal Radiol] 2024 Oct; Vol. 53 (10), pp. 2009-2022. Date of Electronic Publication: 2023 Dec 20.
DOI: 10.1007/s00256-023-04549-4
Abstrakt: During the COVID-19 pandemic, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected millions of people worldwide, with acute respiratory distress syndrome (ARDS) being the most common severe condition of pulmonary involvement. Despite its involvement in the lungs, SARS-CoV-2 causes multiple extrapulmonary manifestations, including manifestations in the musculoskeletal system. Several cases involving bone, joint, muscle, neurovascular and soft tissues were reported shortly after pandemic onset. Even after the acute infection has resolved, many patients experience persistent symptoms and a decrease in quality of life, a condition known as post-COVID syndrome or long COVID. COVID-19 vaccines have been widely available since December 2020, preventing millions of deaths during the pandemic. However, adverse reactions, including those involving the musculoskeletal system, have been reported in the literature. Therefore, the primary goal of this article is to review the main imaging findings of SARS-CoV-2 involvement in the musculoskeletal system, including acute, subacute, chronic and postvaccination manifestations.
(© 2023. The Author(s), under exclusive licence to International Skeletal Society (ISS).)
Databáze: MEDLINE